ES2991081T3 - Procedimiento para preparar 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-desoxi-1-metilamino-D-glucitol - Google Patents

Procedimiento para preparar 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-desoxi-1-metilamino-D-glucitol Download PDF

Info

Publication number
ES2991081T3
ES2991081T3 ES20710987T ES20710987T ES2991081T3 ES 2991081 T3 ES2991081 T3 ES 2991081T3 ES 20710987 T ES20710987 T ES 20710987T ES 20710987 T ES20710987 T ES 20710987T ES 2991081 T3 ES2991081 T3 ES 2991081T3
Authority
ES
Spain
Prior art keywords
formula
compound
dichlorophenyl
sub
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES20710987T
Other languages
English (en)
Spanish (es)
Inventor
Ropero Sergio Rodriguez
Clotet Joan Huguet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inke SA
Original Assignee
Inke SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inke SA filed Critical Inke SA
Application granted granted Critical
Publication of ES2991081T3 publication Critical patent/ES2991081T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES20710987T 2019-04-11 2020-03-19 Procedimiento para preparar 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-desoxi-1-metilamino-D-glucitol Active ES2991081T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382273 2019-04-11
PCT/EP2020/057683 WO2020207753A1 (en) 2019-04-11 2020-03-19 Process for preparing 1-deoxy-1-methylamino-d-glucitol 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate

Publications (1)

Publication Number Publication Date
ES2991081T3 true ES2991081T3 (es) 2024-12-02

Family

ID=66240025

Family Applications (1)

Application Number Title Priority Date Filing Date
ES20710987T Active ES2991081T3 (es) 2019-04-11 2020-03-19 Procedimiento para preparar 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-desoxi-1-metilamino-D-glucitol

Country Status (10)

Country Link
US (1) US12116352B2 (enExample)
EP (1) EP3953339B1 (enExample)
JP (1) JP7622338B2 (enExample)
CN (1) CN113874359B (enExample)
AR (1) AR118647A1 (enExample)
ES (1) ES2991081T3 (enExample)
HR (1) HRP20241374T1 (enExample)
HU (1) HUE068975T2 (enExample)
PL (1) PL3953339T3 (enExample)
WO (1) WO2020207753A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113372290A (zh) * 2021-05-21 2021-09-10 遵义医科大学 一种药物Tafamidis的合成方法
CN113277993B (zh) * 2021-06-06 2023-07-21 湖南第一师范学院 一种Tafamidis及其衍生物的合成方法
CN113735792B (zh) * 2021-09-22 2024-10-18 上海新礼泰药业有限公司 氯苯唑酸葡胺及其中间体的制备方法
KR102657823B1 (ko) * 2022-03-10 2024-04-16 고려대학교 산학협력단 타파미디스의 신규 합성법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2800237C (en) * 2002-12-19 2016-05-17 The Scripps Research Institute Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
JP2006513250A (ja) 2003-01-28 2006-04-20 中国科学院上海薬物研究所 アラニン系化合物、その製造方法及び用途
RU2586330C2 (ru) 2011-09-16 2016-06-10 Пфайзер Инк. Твердые формы ингибитора диссоциации транстиретина
US9499527B2 (en) * 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of familial amyloid polyneuropathy
PT4349406T (pt) * 2014-09-08 2026-02-04 Pfizer Formas sólidas cristalinas de 6-carboxi-2-(3,5-diclorofenil)-benzoxazol para utilização como medicamento
CN107344927A (zh) 2016-05-05 2017-11-14 苏州晶云药物科技有限公司 Tafamidis葡甲胺盐的晶型E及其制备方法和用途

Also Published As

Publication number Publication date
CN113874359B (zh) 2024-07-16
US20220144787A1 (en) 2022-05-12
US12116352B2 (en) 2024-10-15
CN113874359A (zh) 2021-12-31
EP3953339A1 (en) 2022-02-16
EP3953339C0 (en) 2024-09-04
PL3953339T3 (pl) 2025-05-05
JP2022526675A (ja) 2022-05-25
AR118647A1 (es) 2021-10-20
EP3953339B1 (en) 2024-09-04
HRP20241374T1 (hr) 2024-12-20
JP7622338B2 (ja) 2025-01-28
HUE068975T2 (hu) 2025-02-28
WO2020207753A1 (en) 2020-10-15

Similar Documents

Publication Publication Date Title
ES2991081T3 (es) Procedimiento para preparar 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-desoxi-1-metilamino-D-glucitol
US20100160653A1 (en) Docetaxel polymorphs and processes
CN1384108A (zh) 一种制备4"-取代的9-脱氧-9a-氮杂-9a-高红霉素a衍生物的方法
JP2010503722A (ja) シクレソニドとその結晶変異体の調製方法
CA2818984C (en) Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
CN112047888A (zh) 一种合成恩杂鲁胺的方法
EP3565819B1 (en) Solid forms of [(1s)-1-[(2s,4r,5r)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
CN1354753A (zh) 新的中间体,从中制备大环内酯类抗生素试剂的方法
US20110040078A1 (en) Process for the production of telithromycin
CN102199180B (zh) 一种卡培他滨的制备方法
JP2011006379A (ja) {2−アミノ−1,4−ジヒドロ−6−メチル−4−(3−ニトロフェニル)−3,5−ピリジンジカルボン酸3−(1−ジフェニルメチルアゼチジン−3−イル)エステル5−イソプロピルエステル}(アゼルニジピン)の再結晶方法、アゼルニジピンのイソプロピルアルコール付加体、およびアゼルニジピンの製造方法
ES2741505T3 (es) Procedimiento para la preparación de acetato de abiraterona y sus productos intermedios
CN115710209B (zh) 用于制备卡前列素和卡前列素缓血酸胺的方法和中间物,以及由其制得的卡前列素缓血酸胺
ES2964891T3 (es) Un proceso para la preparación de compuestos de 2-amino-1,3-propanodiol y sales de los mismos
JP2024069193A (ja) ブロモドメイン阻害剤の合成方法
US12012421B2 (en) Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
US12012420B2 (en) Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
JP2025501596A (ja) 酸化型グルタチオン及びその結晶形並びに不純物の調製方法
US20080182998A1 (en) Novel crystalline mycophenolate sodium polymorph and processes to manufacture same
TWI861431B (zh) 用於製備卡前列素及卡前列素緩血酸胺之方法及中間物,及由其製得之卡前列素緩血酸胺
US20060247427A1 (en) Process to obtain 6-O-methylerythromycin a (clarithromycin)_form II
JP5192807B2 (ja) シュードウリジン保護体の安定結晶
WO2014047849A1 (zh) 细胞色素p450单加氧酶抑制剂中间体及其制法和用途
JP2021059607A (ja) アジルサルタンアルキルエステル、アジルサルタンメチルエステルの製造方法、及びアジルサルタンの製造方法
JPS58164573A (ja) 1−(4−クロロベンゾイル)−5−メトキシ−2−メチル−3−インド−ルアセトキシ酢酸類の製法